92 related articles for article (PubMed ID: 19063602)
1. Conformational switch upon phosphorylation: human CDK inhibitor p19INK4d between the native and partially folded state.
Löw C; Homeyer N; Weininger U; Sticht H; Balbach J
ACS Chem Biol; 2009 Jan; 4(1):53-63. PubMed ID: 19063602
[TBL] [Abstract][Full Text] [Related]
2. Folding mechanism of an ankyrin repeat protein: scaffold and active site formation of human CDK inhibitor p19(INK4d).
Löw C; Weininger U; Zeeb M; Zhang W; Laue ED; Schmid FX; Balbach J
J Mol Biol; 2007 Oct; 373(1):219-31. PubMed ID: 17804013
[TBL] [Abstract][Full Text] [Related]
3. Protein folding and stability of human CDK inhibitor p19(INK4d).
Zeeb M; Rösner H; Zeslawski W; Canet D; Holak TA; Balbach J
J Mol Biol; 2002 Jan; 315(3):447-57. PubMed ID: 11786024
[TBL] [Abstract][Full Text] [Related]
4. Biological regulation via ankyrin repeat folding.
Barrick D
ACS Chem Biol; 2009 Jan; 4(1):19-22. PubMed ID: 19146478
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation-induced unfolding regulates p19
Kumar A; Gopalswamy M; Wolf A; Brockwell DJ; Hatzfeld M; Balbach J
Proc Natl Acad Sci U S A; 2018 Mar; 115(13):3344-3349. PubMed ID: 29531090
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the complex of the cyclin D-dependent kinase Cdk6 bound to the cell-cycle inhibitor p19INK4d.
Brotherton DH; Dhanaraj V; Wick S; Brizuela L; Domaille PJ; Volyanik E; Xu X; Parisini E; Smith BO; Archer SJ; Serrano M; Brenner SL; Blundell TL; Laue ED
Nature; 1998 Sep; 395(6699):244-50. PubMed ID: 9751051
[TBL] [Abstract][Full Text] [Related]
7. A minimum folding unit in the ankyrin repeat protein p16(INK4).
Zhang B; Peng Zy
J Mol Biol; 2000 Jun; 299(4):1121-32. PubMed ID: 10843863
[TBL] [Abstract][Full Text] [Related]
8. Comparisons of the conformational stability of cyclin-dependent kinase (CDK) 4-interacting ankyrin repeat (AR) proteins.
Guo Y; Mahajan A; Yuan C; Joo SH; Weghorst CM; Tsai MD; Li J
Biochemistry; 2009 May; 48(19):4050-62. PubMed ID: 19320462
[TBL] [Abstract][Full Text] [Related]
9. Backbone dynamics of the CDK inhibitor p19(INK4d) studied by 15N NMR relaxation experiments at two field strengths.
Renner C; Baumgartner R; Noegel AA; Holak TA
J Mol Biol; 1998; 283(1):221-9. PubMed ID: 9761685
[TBL] [Abstract][Full Text] [Related]
10. Structure of the cyclin-dependent kinase inhibitor p19Ink4d.
Luh FY; Archer SJ; Domaille PJ; Smith BO; Owen D; Brotherton DH; Raine AR; Xu X; Brizuela L; Brenner SL; Laue ED
Nature; 1997 Oct; 389(6654):999-1003. PubMed ID: 9353127
[TBL] [Abstract][Full Text] [Related]
11. Protein conformational transitions coupled to binding in molecular recognition of unstructured proteins: deciphering the effect of intermolecular interactions on computational structure prediction of the p27Kip1 protein bound to the cyclin A-cyclin-dependent kinase 2 complex.
Verkhivker GM
Proteins; 2005 Feb; 58(3):706-16. PubMed ID: 15609350
[TBL] [Abstract][Full Text] [Related]
12. Denaturant-dependent conformational changes in a beta-trefoil protein: global and residue-specific aspects of an equilibrium denaturation process.
Latypov RF; Liu D; Jacob J; Harvey TS; Bondarenko PV; Kleemann GR; Brems DN; Raibekas AA
Biochemistry; 2009 Nov; 48(46):10934-47. PubMed ID: 19839644
[TBL] [Abstract][Full Text] [Related]
13. NMR structural characterization of the CDK inhibitor p19INK4d.
Kalus W; Baumgartner R; Renner C; Noegel A; Chan FK; Winoto A; Holak TA
FEBS Lett; 1997 Jan; 401(2-3):127-32. PubMed ID: 9013872
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin/proteasome-mediated degradation of p19INK4d determines its periodic expression during the cell cycle.
Thullberg M; Bartek J; Lukas J
Oncogene; 2000 Jun; 19(24):2870-6. PubMed ID: 10851091
[TBL] [Abstract][Full Text] [Related]
15. Unfolding transition state and intermediates of the tumor suppressor p16INK4a investigated by molecular dynamics simulations.
Interlandi G; Settanni G; Caflisch A
Proteins; 2006 Jul; 64(1):178-92. PubMed ID: 16596641
[TBL] [Abstract][Full Text] [Related]
16. Frequent loss of p19INK4D expression in hepatocellular carcinoma: relationship to tumor differentiation and patient survival.
Morishita A; Gong J; Deguchi A; Tani J; Miyoshi H; Yoshida H; Himoto T; Yoneyama H; Mori H; Kato K; Kurokohchi K; Deguchi K; Izuishi K; Suzuki Y; Kushida Y; Haba R; Iwama H; Watanabe S; D'Armiento J; Masaki T
Oncol Rep; 2011 Dec; 26(6):1363-8. PubMed ID: 21901251
[TBL] [Abstract][Full Text] [Related]
17. Lack of p19INK4d in human testicular germ-cell tumours contrasts with high expression during normal spermatogenesis.
Bartkova J; Thullberg M; Rajpert-De Meyts E; Skakkebaek NE; Bartek J
Oncogene; 2000 Aug; 19(36):4146-50. PubMed ID: 10962575
[TBL] [Abstract][Full Text] [Related]
18. Structural insights into an equilibrium folding intermediate of an archaeal ankyrin repeat protein.
Löw C; Weininger U; Neumann P; Klepsch M; Lilie H; Stubbs MT; Balbach J
Proc Natl Acad Sci U S A; 2008 Mar; 105(10):3779-84. PubMed ID: 18305166
[TBL] [Abstract][Full Text] [Related]
19. CDK2 and PKA mediated-sequential phosphorylation is critical for p19INK4d function in the DNA damage response.
Marazita MC; Ogara MF; Sonzogni SV; Martí M; Dusetti NJ; Pignataro OP; Cánepa ET
PLoS One; 2012; 7(4):e35638. PubMed ID: 22558186
[TBL] [Abstract][Full Text] [Related]
20. Characterization and further stabilization of designed ankyrin repeat proteins by combining molecular dynamics simulations and experiments.
Interlandi G; Wetzel SK; Settanni G; Plückthun A; Caflisch A
J Mol Biol; 2008 Jan; 375(3):837-54. PubMed ID: 18048057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
